ROTHFUSS CRISTIN (EVP, General Counsel) received a stock award from SAREPTA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 9/5/2025ACC: 0001193125-25-197422
Officer· EVP, General Counsel
Since Mar 2026
+118.88K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
118.88K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+93.88K
Price / share
—
Trade value
—
% of position
444.7%
9/3/2025
21.11K→114.98K
Common Stock
Direct
Shares
+25K
Price / share
—
Trade value
—
% of position
21.7%
9/3/2025
114.98K→139.99K
Total
Net shares
+118.88K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/3/2025 | A · Award | +93.88K | — | — | 444.7% | 21.11K | 114.98K |
| Common Stock Direct | 9/3/2025 | A · Award | +25K | — | — | 21.7% | 114.98K | 139.99K |
| Total | +118.88K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported